Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PopVax HCV Vaccine
- Development stage
- Preclinical
- Lead developer
- PopVax
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
PopVax HCV Vaccine is a preclinical-stage vaccine candidate being developed by PopVax for the prevention of Hepatitis C virus (HCV) infection. The vaccine utilizes a proprietary mRNA-encoded virus-like particle (VLP) platform, which integrates machine learning-driven protein design with mRNA delivery systems. This approach is designed to deliver genetic instructions that enable the in vivo assembly of VLPs displaying Hepatitis C viral antigens, thereby mimicking the structure of the virus to stimulate a robust and protective immune response. As of early 2026, the program is in late preclinical development, with Phase 1 clinical trials projected to commence in 2027. It is positioned as a potential first-in-class vaccine for a disease that currently lacks an effective preventative immunization.
- Other names
- HCV VaccineHepatitis C vaccinemRNA-encoded VLP Hepatitis C vaccine
Beyond the preview
Go deeper on PopVax HCV Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PopVax HCV Vaccine.